Home Contact Us Links TwitterLinkedIn
The RADARS System measures rates of abuse, misuse and diversion throughout the United States, contributing to the understanding of trends and aiding the development of effective interventions. These data assist pharmaceutical companies in fulfillment of their regulatory obligations such as risk evaluation and mitigation strategies (REMS).
Analyses can be performed for conferences and publications. In addition, our staff are experienced in protocol development, statistical analysis plans, and providing reports for the FDA.
RADARS® System is proud to announce the release of “Trends in Opioid Analgesic Abuse and Mortality in the United States” in the New England Journal of Medicine.
After decades of rising prescription opioid abuse rates, data shows that abuse is on the decline. Beginning in 2010, rates began to plateau and proceeded to decline from 2011-2013, bending the curve of opioid abuse. These findings suggest federal, state and local interventions are making progress in controlling abuse. Although rates are encouraging, the rate of heroin deaths was found to be inversely related to the abuse of prescription opioids warranting further investigation. Read more.